The McGill International TB Centre, situated at the McGill University Health Centre in Montreal, Canada, is a world leader in the interdisciplinary study of TB, bringing together researchers in biomedical, clinical, epidemiological and social determinants of TB and other mycobacterial diseases.

The Stop TB Partnership is leading the way to a world without tuberculosis (TB), a disease that is curable but still kills three people every minute. Founded in 2001, the Partnership's mission is to serve every person who is vulnerable to TB and ensure that high-quality diagnosis, treatment and care is available to all who need it. They operate through a secretariat hosted by UNOPS in Geneva, Switzerland and seven working groups whose role is to accelerate progress on access to TB diagnosis and treatment; research and development for new TB diagnostics, drugs and vaccines; and tackling drug resistant- and HIV-associated TB. The secretariat is governed by a Coordinating Board that sets strategic direction for the global fight against TB. The Partnership is recognized as a unique international body with the power to align actors all over the world in the fight against TB. The participation of a wide range of constituencies gives us credibility and the broad range of medical, social and financial expertises needed to defeat TB.

Unitaid is a hosted partnership of the World Health Organization (WHO) that invests in new ways to prevent, diagnose and treat HIV/AIDS, tuberculosis and malaria more quickly, more cheaply and more effectively

The World Health Organization is a specialized agency of the United Nations established in 1948 to further international cooperation for improved public health conditions. The WHO Global TB Programme is responsible for coordinating WHO's global efforts to end TB